A Sunscreen Formulation And Uses Thereof

Itc Limited
Granted App No 201641006829 Patent 488398 Chemical

Patent information

IP India · live record
Application number
201641006829
Filing date
26 February 2016
Status
Granted
Legal status
Inforce
Publication number
47/2017
Publication type
INA
Invention field
Chemical
Patent number
488398
Grant date
23 December 2023
Next renewal due
26 February 2027

Abstract

The present disclosure provides a sunscreen formulation with superior sensorial features, comprising a combination of sunscreen agents, and an emulsifier at particular weight concentrations to achieve said characteristics.

Applicants

1
India
ITC LIMITED ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058

Inventors

3
India
KIRUBAKARAN, BalavaishnaviITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India
India
PASUPULATE, SravanthiITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India
India
MURALI, DeepaITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India

Claims

9
1 A sunscreen formulation comprising: a. a combination of phenylbenzimidazole sulfonic acid, disodium phenyl dibenzimidazole tetrasulfonate, and ethylhexyl methoxycinnamate; and b. hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60, wherein said combination of phenylbenzimidazole sulfonic acid, disodium phenyl dibenzimidazole tetrasulfonate, and ethylhexyl methoxycinnamate weight concentration in said formulation is in the range of 0.3-20%; and hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 weight concentration in said formulation is in the range of 6-8%,
2 The formulation as claimed in claim 1, said formulation further comprising: a. at least one bodying agent; b. at least one neutralizer; c. at least one film former; d. at least one chelant; and e. water.
3 The formulation as claimed in claim 1, wherein phenylbenzimidazole sulfonic acid weight concentration in said formulation is in the range of 0.1-5%, disodium phenyl dibenzimidazole tetrasulfonate weight concentration in said formulation is in the range of 0.1-5%, and ethylhexyl methoxycinnamate weight concentration in said formulation is in the range of 0.1-10%.
4 The formulation as claimed in claim 3, wherein phenylbenzimidazole sulfonic acid weight concentration in said formulation is 2.5%, disodium phenyl dibenzimidazole tetrasulfonate weight concentration in said formulation is 2.2% and ethylhexyl methoxycinnamate weight concentration in said formulation is 9.75%.
5 The formulation as claimed in claim 1, wherein hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 weight concentration in said formulation is 6.5%.
6 The formulation as claimed in claim 2, wherein a. at least one bodying agent is selected from the group consisting of acrylates/C10-30 alkyl acrylate crosspolymer with electrolyte tolerance (Ultrez 20, Ultrez 21, or Ultrez 30), having weight concentration in said formulation in the range of 0.1-2%; b. at least one neutralizer is selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonium hydroxide, diethanolamine, triethanolamine, 2-dimethylamino-2-methyl-1-propanol (DAMP), and 2-aminomethyl-1propanol (aminomethyl propanol) (AMP), in quantity sufficient to achieve a pH of said formulation in the range of 6-8; c. at least one film former is selected from the group consisting of acrylate/octylacrylamide copolymer, acrylates copolymer, acrylates/C12-22 alkyl methacrylate copolymer, butylated PVP, and VA/butyl maleate/isobornyl acrylate copolymer vinyl caprolactam/VP/dimethylaminoethyl methacrylate copolymer, having weight concentration in said formulation in the range of 0.5-1.5%; d. at least one chelant is selected from the group consisting of dimercaptosuccinic acid (DMSA), dimercapto-propane sulfonate (DMPS), alpha lipoic acid (ALA), calcium disodium versante (CaNa2-EDTA), disodium EDTA, and dimercaprol (BAL), having weight concentration in the range of 0.05-0.1%; and e. water up to 100%.
7 The formulation as claimed in claim 6, comprising: a. disodium EDTA having weight concentration in said formulation of 0.05%; b. acrylates copolymer having weight concentration in said formulation of 1%; c. triethanolamine having weight concentration in said formulation of 2.45%; d. acrylates/C10-30 alkyl acrylate crosspolymer having weight concentration in said formulation of 0.1%; e. ethyl hexyl methoxycinnamate having weight concentration in said formulation of 9.75%; f. disodium phenyl dibenzimidazole tetrasulfonate having weight concentration in said formulation of 2.2%; g. phenylbenzimidazole sulfonic acid having weight concentration in said formulation of 2.5%; h. hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 having weight concentration in said formulation of 6.5%; and i. water to make up to 100%.
8 A method of preparing a formulation as claimed in claim 7, said method comprising: a. preparing a water phase by contacting water, disodium EDTA, acrylates copolymer, and acrylates/C10-30 alkyl acrylate crosspolymer at a temperature in the range of 25-300C and mixing at 500-650 rpm to obtain a mixture A; b. contacting triethanolamine to said mixture A to obtain a water phase mixture B; c. contacting disodium phenyl dibenzimidazole tetrasulfonate, and phenylbenzimidazole sulfonic acid with triethanolamine to obtain a pre-neutralized sunscreen solution C having pH in the range of 6-8; d. contacting pre-neutralized sunscreen solution C with water phase mixture B to obtain a mixture D; and e. contacting ethyl hexyl methoxycinnamate, and hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 with mixture D at a temperature in the range of 25-300C under continuous stirring at 450-500 rpm obtain said formulation.
9 A method of preparing a formulation as claimed in claim 2, said method comprising: a. preparing a water phase by contacting water, at least one chelant, at least one film former, and at least one bodying agent at a temperature in the range of 25-30°C and mixing at 500-650 rpm to obtain a mixture A; b. contacting at least one neutralizer to said mixture A to obtain a water phase mixture B; c. contacting disodium phenyl dibenzimidazole tetrasulfonate, and phenylbenzimidazole sulfonic acid with at least one neutralizer to obtain a pre-neutralized sunscreen solution C having pH in the range of 6-8; d. contacting pre-neutralized sunscreen solution C with water phase mixture B to obtain a mixture D; and e. contacting ethyl hexyl methoxycinnamate, and hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 with mixture D at a temperature in the range of 25-30°C under continuous stirring at 450-500 rpm obtain said formulation. , Description:As Attached

Specification

Show full textCollapse

Claims:1. A sunscreen formulation comprising: a. a combination of phenylbenzimidazole sulfonic acid, disodium phenyl dibenzimidazole tetrasulfonate, and ethylhexyl methoxycinnamate; and b. hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60, wherein said combination of phenylbenzimidazole sulfonic acid, disodium phenyl dibenzimidazole tetrasulfonate, and ethylhexyl methoxycinnamate weight concentration in said formulation is in the range of 0.3-20%; and hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 weight concentration in said formulation is in the range of 6-8%, 2. The formulation as claimed in claim 1, said formulation further comprising: a. at least one bodying agent; b. at least one neutralizer; c. at least one film former; d. at least one chelant; and e. water. 3. The formulation as claimed in claim 1, wherein phenylbenzimidazole sulfonic acid weight concentration in said formulation is in the range of 0.1-5%, disodium phenyl dibenzimidazole tetrasulfonate weight concentration in said formulation is in the range of 0.1-5%, and ethylhexyl methoxycinnamate weight concentration in said formulation is in the range of 0.1-10%. 4. The formulation as claimed in claim 3, wherein phenylbenzimidazole sulfonic acid weight concentration in said formulation is 2.5%, disodium phenyl dibenzimidazole tetrasulfonate weight concentration in said formulation is 2.2% and ethylhexyl methoxycinnamate weight concentration in said formulation is 9.75%. 5. The formulation as claimed in claim 1, wherein hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 weight concentration in said formulation is 6.5%. 6. The formulation as claimed in claim 2, wherein a. at least one bodying agent is selected from the group consisting of acrylates/C10-30 alkyl acrylate crosspolymer with electrolyte tolerance (Ultrez 20, Ultrez 21, or Ultrez 30), having weight concentration in said formulation in the range of 0.1-2%; b. at least one neutralizer is selected from the group consisting of sodium hydroxide, potassium hydroxide, ammonium hydroxide, diethanolamine, triethanolamine, 2-dimethylamino-2-methyl-1-propanol (DAMP), and 2-aminomethyl-1propanol (aminomethyl propanol) (AMP), in quantity sufficient to achieve a pH of said formulation in the range of 6-8; c. at least one film former is selected from the group consisting of acrylate/octylacrylamide copolymer, acrylates copolymer, acrylates/C12-22 alkyl methacrylate copolymer, butylated PVP, and VA/butyl maleate/isobornyl acrylate copolymer vinyl caprolactam/VP/dimethylaminoethyl methacrylate copolymer, having weight concentration in said formulation in the range of 0.5-1.5%; d. at least one chelant is selected from the group consisting of dimercaptosuccinic acid (DMSA), dimercapto-propane sulfonate (DMPS), alpha lipoic acid (ALA), calcium disodium versante (CaNa2-EDTA), disodium EDTA, and dimercaprol (BAL), having weight concentration in the range of 0.05-0.1%; and e. water up to 100%. 7. The formulation as claimed in claim 6, comprising: a. disodium EDTA having weight concentration in said formulation of 0.05%; b. acrylates copolymer having weight concentration in said formulation of 1%; c. triethanolamine having weight concentration in said formulation of 2.45%; d. acrylates/C10-30 alkyl acrylate crosspolymer having weight concentration in said formulation of 0.1%; e. ethyl hexyl methoxycinnamate having weight concentration in said formulation of 9.75%; f. disodium phenyl dibenzimidazole tetrasulfonate having weight concentration in said formulation of 2.2%; g. phenylbenzimidazole sulfonic acid having weight concentration in said formulation of 2.5%; h. hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 having weight concentration in said formulation of 6.5%; and i. water to make up to 100%. 8. A method of preparing a formulation as claimed in claim 7, said method comprising: a. preparing a water phase by contacting water, disodium EDTA, acrylates copolymer, and acrylates/C10-30 alkyl acrylate crosspolymer at a temperature in the range of 25-300C and mixing at 500-650 rpm to obtain a mixture A; b. contacting triethanolamine to said mixture A to obtain a water phase mixture B; c. contacting disodium phenyl dibenzimidazole tetrasulfonate, and phenylbenzimidazole sulfonic acid with triethanolamine to obtain a pre-neutralized sunscreen solution C having pH in the range of 6-8; d. contacting pre-neutralized sunscreen solution C with water phase mixture B to obtain a mixture D; and e. contacting ethyl hexyl methoxycinnamate, and hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 with mixture D at a temperature in the range of 25-300C under continuous stirring at 450-500 rpm obtain said formulation. 9. A method of preparing a formulation as claimed in claim 2, said method comprising: a. preparing a water phase by contacting water, at least one chelant, at least one film former, and at least one bodying agent at a temperature in the range of 25-30°C and mixing at 500-650 rpm to obtain a mixture A; b. contacting at least one neutralizer to said mixture A to obtain a water phase mixture B; c. contacting disodium phenyl dibenzimidazole tetrasulfonate, and phenylbenzimidazole sulfonic acid with at least one neutralizer to obtain a pre-neutralized sunscreen solution C having pH in the range of 6-8; d. contacting pre-neutralized sunscreen solution C with water phase mixture B to obtain a mixture D; and e. contacting ethyl hexyl methoxycinnamate, and hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (and) isohexadecane (and) polysorbate 60 with mixture D at a temperature in the range of 25-30°C under continuous stirring at 450-500 rpm obtain said formulation. , Description:As Attached

Documents

Sign in to open
Orders
Section
Application documents
1 Form 5 [26-02-2016(online)].pdf 26 Feb 2016
2 Form 3 [26-02-2016(online)].pdf 26 Feb 2016
3 Description(Complete) [26-02-2016(online)].pdf 26 Feb 2016
4 Other Patent Document [05-07-2016(online)].pdf 05 Jul 2016
5 Form 26 [05-07-2016(online)].pdf 05 Jul 2016
6 201641006829-Power of Attorney-110716.pdf 29 Jul 2016
7 201641006829-Form 1-110716.pdf 29 Jul 2016
8 201641006829-Correspondence-F1-PA-110716.pdf 29 Jul 2016
9 201641006829-FORM 18 [07-01-2020(online)].pdf 07 Jan 2020
10 201641006829-FER.pdf 03 Aug 2020
11 201641006829-FORM 4(ii) [02-02-2021(online)].pdf 02 Feb 2021
12 201641006829-OTHERS [26-04-2021(online)].pdf 26 Apr 2021
13 201641006829-FER_SER_REPLY [26-04-2021(online)].pdf 26 Apr 2021
14 201641006829-CLAIMS [26-04-2021(online)].pdf 26 Apr 2021
15 201641006829-Correspondence to notify the Controller [01-09-2021(online)].pdf 01 Sep 2021
16 201641006829-Written submissions and relevant documents [21-09-2021(online)].pdf 21 Sep 2021
17 201641006829-US(14)-HearingNotice-(HearingDate-07-09-2021).pdf 17 Oct 2021
18 201641006829-PatentCertificate23-12-2023.pdf 23 Dec 2023
19 201641006829-IntimationOfGrant23-12-2023.pdf 23 Dec 2023
Search strategy
1ss201641006829E_03-08-2020.pdf

ERegister / renewals

Inforce
3rd Renewed 12 Jan 2024 Period 26 Feb 2018 – 26 Feb 2019 · CBR 2674 · Certificate 7626 ₹4,000
4th Renewed 12 Jan 2024 Period 26 Feb 2019 – 26 Feb 2020 · CBR 2674 · Certificate 7627 ₹4,000
5th Renewed 12 Jan 2024 Period 26 Feb 2020 – 26 Feb 2021 · CBR 2674 · Certificate 7628 ₹4,000
6th Renewed 12 Jan 2024 Period 26 Feb 2021 – 26 Feb 2022 · CBR 2674 · Certificate 7629 ₹4,000
7th Renewed 12 Jan 2024 Period 26 Feb 2022 – 26 Feb 2023 · CBR 2674 · Certificate 7630 ₹12,000
8th Renewed 12 Jan 2024 Period 26 Feb 2023 – 26 Feb 2024 · CBR 2674 · Certificate 7631 ₹12,000
9th Renewed 12 Jan 2024 Period 26 Feb 2024 – 26 Feb 2025 · CBR 2674 · Certificate 7632 ₹12,000
10th Renewed 30 Jan 2025 Period 26 Feb 2025 – 26 Feb 2026 · CBR 5377 · Certificate 8010 ₹12,000
11th Renewed 11 Feb 2026 Period 26 Feb 2026 – 26 Feb 2027 · CBR 10328 · Certificate 11428 ₹24,000